Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments

Conventional analgesics prescribed for osteoarthritis offer inadequate pain relief and are associated with several adverse events.

Related Keywords

Tissuegene Invossa ,Techfields Pharma ,Organogenesis Holdings Renu ,Solutions For Drug Substance Logistics ,Organogenesis Holdings ,Bone Therapeutics ,Xalud Therapeutics ,Centrexion Therapeutics ,Biosplice Therapeutics ,Drug Delivery Systems ,Dfend Solutions ,Drug Substance ,Vacuum Drying ,